Skip to main content

Table 2 Clinical characteristics of the study tumor samples

From: Vav2 protein overexpression marks and may predict the aggressive subtype of ductal carcinoma in situ

Characteristic Status IBC (%) CIS (%)
Tumor size pT1 13.3  
pT2 65.3  
pT3 19.4  
pT4 1.0  
No report 1.0  
Lymph node status pN0 44.9  
pN1 20.4  
pN2 19.4  
pN3 8.2  
pNx 6.1  
No report 1.0  
Grade (Nottingham score) I 2.0 4.2
II 38.8 43.7
III 46.9 38.0
No report 12.2 14.1
Estrogen Receptor Negative 33.7 32.4
Positive 65.3 67.6
No report 1.0 0.0
Progesterone Receptor Negative 43.9 39.4
Positive 55.1 60.6
No report 1.0 0
HER2/ErbB2/neu Negative/ Equivocal 81.6 69.0
Positive 17.3 21.1
No report 1.0 9.9